1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow RAS Mutation: new trials by email Literature Review of RAS Mutation trials Research Report on RAS Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB Bevacizumab, Cetuximab, 5-FU - Colorectal Cancer, Metastatic Colorectal Cancer | Phase 3 | Active not recruiting | Azienda USL Reggio Emilia - IRCCS | 280 | 2021-04-30 | 2026-07-24 |
Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
Bevacizumab (1) · Cetuximab (1) · Fluorouracil (1) · Irinotecan (1) · Leucovorin (1)
Azienda USL Reggio Emilia - IRCCS (1)
Italy (1)
Erika Gervasi (1) · Irene De Simone (1)